The rubber meets the road for the dietary supplement industry's chief expectation from the Trump administration as FDA asks regulated industries for comments on how to "achieve meaningful burden reduction."
In notices prepared for the Sept
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?